The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

17576–17600 of 39601

  • SevereFDA (Drugs)·D-0986-2018·2018-08-01

    Teva Recalls Valsartan Tablets Due to Carcinogen Impurity in API

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan Tablets 40 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan Tablets, USP 40 mg, 30-count bottle (NDC 0591-2167-30), 90-count bottle (NDC 0591-2167-19), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0975-2018·2018-08-01

    Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc. is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0985-2018·2018-08-01

    Teva Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 320 mg/25 mg tablets, USP, 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2318-19.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0966-2018·2018-08-01

    Major Pharmaceuticals Recalls Valsartan Tablets Due to Carcinogen Impurity

    Major Pharmaceuticals is recalling specific lots of 80 mg Valsartan tablets because a carcinogen impurity was detected in the active ingredient.

    Product
    Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by: Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0968-2018·2018-08-01

    Prinston Recalls Valsartan Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc. is recalling Valsartan 40 mg tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN — VALSARTAN (VALSARTAN)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0972-2018·2018-08-01

    Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0988-2018·2018-08-01

    Teva Recalls Valsartan Tablets Due to Carcinogen Impurity in API

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan Tablets 160 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0982-2018·2018-08-01

    Teva Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Teva Pharmaceuticals is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 160 mg/12.5 mg tablets, USP 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2316-19.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0967-2018·2018-08-01

    Major Pharmaceuticals Recalls Valsartan Tablets Due to Carcinogen Impurity

    Major Pharmaceuticals is recalling specific lots of 160 mg Valsartan tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Unit Dose Valsartan Tablets, USP. 160 mg. Rx only.,Distributed by: Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61. NDC# 0904-6595-61.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0970-2018·2018-08-01

    Prinston Recalls Valsartan Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc is recalling Valsartan tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN — VALSARTAN (VALSARTAN)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0969-2018·2018-08-01

    Prinston Recalls Valsartan Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc is recalling Valsartan tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN — VALSARTAN (VALSARTAN)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Food)·F-1676-2018·2018-08-01

    May Flower 3+2 Soda Crackers Recalled for Undeclared Milk

    May Flower International Inc. is recalling 3+2 Soda Crackers in New York because the product contains undeclared milk.

    Product
    3+2 Soda Crackers (CREAM FLAVOUR)(S) packaged in a 4.4 oz, yellow package, UPC: 6 919892 633101
    Category
    Food
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0976-2018·2018-08-01

    Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0973-2018·2018-08-01

    Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc. is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0974-2018·2018-08-01

    Prinston Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Prinston Pharmaceutical Inc is recalling Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    VALSARTAN AND HYDROCHLOROTHIAZIDE — VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Devices)·Z-2548-2018·2018-08-01

    Cayenne Medical Recalls AperFix Femoral Implant Coring Removal Drills

    Cayenne Medical Inc. is recalling specific models of the AperFix Femoral Implant Coring Removal Drill due to a trend of premature wear and breakage identified in 2010.

    Product
    AperFix Femoral Implant Coring Removal Drill, labeled as the following: a. Femoral Removal Coring Reamer 9mm, Model Number CM-7109; b. Femoral Removal Coring Reamer 10mm, Model Number CM-7110; c. Femoral Removal Coring Reamer 11mm, Model Number CM-7111; d. Femoral…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0983-2018·2018-08-01

    Teva Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 160 mg/25 mg tablets, USP 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2317-19.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0989-2018·2018-08-01

    Teva Recalls Valsartan Tablets Due to Carcinogen Impurity in API

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan Tablets 320 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan Tablets, USP 320 mg, 90-count bottle (NDC 0591-2170-19), 500-count bottle (NDC 0591-2170-05), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Food)·F-1671-2018·2018-08-01

    Tilgner's Alaskan Salmon Recalls Sockeye Salmon Pieces for Listeria Risk

    Tilgner's Alaskan Salmon is recalling Canoodles coarse ground cold smoked dehydrated shelf stable sockeye salmon pieces due to potential Listeria monocytogenes contamination.

    Product
    Canoodles (ACN) coarse ground cold smoked dehydrated shelf stable sockeye salmon pieces
    Category
    Food
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0984-2018·2018-08-01

    Teva Recalls Valsartan and Hydrochlorothiazide Tablets Due to Carcinogen Impurity

    Teva Pharmaceuticals USA is recalling specific lots of Valsartan and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.

    Product
    Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 320 mg/12.5 mg tablets, USP, 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2318-19
    Category
    Drug
    Distribution
    2 states
  • SevereCPSC·18755·2018-07-31

    Matrix Fitness Ascent Trainers and Ellipticals Recalled for Fire Hazard

    Johnson Health Tech is reannouncing a recall of Matrix fitness machines due to a fire hazard caused by moisture buildup in the power socket.

    Product
    Ascent Trainer® by Matrix and Matrix fitness elliptical
    Category
    Consumer Product
    Distribution
    Distributed nationwide
  • SevereNHTSA·18E065000·2018-07-30

    TAP Recalls Pro Comp Extended Thread Lug Nuts for Seating Issues

    TAP Worldwide is recalling specific Pro Comp Extended Thread Lug Nuts that may not seat properly, potentially causing wheel detachment and loss of vehicle control.

    Product
    WHEELS:LUGS/NUTS/BOLTS/STUDS recall
    Category
    Vehicle
    Distribution
    Distributed nationwide